Report #2860309

Received Sep 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 37 yrs
State: DC
Recovered: Unknown
Vaccinated: Aug 4, 2025
Onset: Aug 4, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
TDAP	TDAP (BOOSTRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	7KD5B	—

Symptoms (1)

Product storage error

Symptom narrative

Vaccine administration after temperature excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 37-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 7KD5B, expiry date 14-JUN-2027) for prophylaxis. On 04-AUG-2025, the patient received Boostrix. On 04-AUG-2025, an unknown time after receiving Boostrix, the patient experienced incorrect storage of drug (Verbatim: Vaccine administration after temperature excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date:29-AUG-2025 This case is 1 of 3 cases reported by same reporter.; Sender's Comments: GSK-US2025111575:same reporter, different patient GSK-US2025111574:same reporter, different patient